Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,827 total articles
AppLovin's Axon ad engine is increasingly cited as the company's differentiator in a crowded adtech market. The stock has pulled back into oversold territory after a strong 2025; this trade targets a mid-term rebound near the 50-day moving average while limiting downside with a tight stop. Risk remains elevated given rich multiples and competitive …
Sterling Infrastructure (STRL) has slipped back from its 52-week high but still sits on a durable multi-year growth runway driven by e-infrastructure and transportation work. Fundamentals — $11.7B market cap, $9.46 EPS, strong free cash flow of $362.7M and conservative leverage — support a Buy-on-weakness trade with defined entry, stop and target l…
Western Digital ($WDC) is a direct beneficiary of the multi-year AI memory supercycle. Recent weakness offers a way to add exposure to a company with strong profitability, recurring free cash flow, and sold-out capacity across key product lines. This trade idea lays out an entry at $255.49, a stop at $220.00 and a primary target of $375.00 over a 1…
Gold Fields (GFI) yields ~1.5% today but offers leveraged exposure to gold prices through operating scale, short-covering potential and a valuation that looks reasonable at a $37.8B market cap and a P/E of ~10.6. We lay out a long trade at $44.00 with a $55.00 target and a $38.50 stop for a defined-risk, event-driven position over the next several …
Shares of Sandisk (SNDK) have been punished after news about Google's TurboQuant compression algorithm. The sell-off creates a tactical long opportunity. Sandisk's exposure to robust AI infrastructure demand, positive free cash flow, and limited near-term supply elasticity argue the stock's downside is smaller than current market moves imply. Trade…
National Vision is showing signs of sustainable improvement: positive institutional accumulation, margin discipline and expansion into higher-value customers. Fundamentals leave room for upside around near-term resistance, while capital structure and free cash flow provide a safety buffer. This trade idea outlines an entry at $24.50, a stop at $22.…
DoorDash is trading close to its 52-week low despite healthy revenue growth, improving cash flow, and visible margin levers from grocery and logistics. We lay out an actionable long trade with concrete entry, stop and target, and explain why the risk/reward favors a constructive position over the next 180 trading days.
Paysign surged after a March 25, 2026 quarter that beat revenue expectations and issued 2026 revenue and earnings guidance. The business is capital-light with strong free cash flow, a modest enterprise value, and visible tailwinds from pharma and plasma verticals. Technical momentum is strong but stretched; this trade idea lays out an entry at $5.7…
Microsoft is trading near pre-COVID valuation multiples (P/E ~22) despite accelerating cloud and AI revenue and $77.4B in free cash flow. The stock looks technically oversold (RSI ~24.7) after a sector-wide derating. This trade targets a mean-reversion to a more constructive mid-cycle multiple: entry $363.50, stop $345.00, target $420.00 over a mid…
Ciena sits at the physical layer that hyperscalers and cloud providers must buy to feed AI models. Strong order backlog, double-digit revenue tailwinds and healthy free cash flow argue for a buy-on-pullback approach. This trade plan targets a measured rebound while acknowledging valuation and execution risks.
Symbotic (SYM) is a leading warehouse automation specialist with a $22B+ backlog, improving margins, and substantial free cash flow. The stock has pulled back into the high-$40s after a post-earnings wobble. I view the current price as a tactical buying opportunity for a mid-term swing trade, sized for disciplined risk management.
ASE (ASX) looks like an actionable long: the stock is digesting a pullback near $20.88 while industry reports point to multi-year growth in high-end packaging and a capacity squeeze for premium solutions. We lay out a mid-term trade with precise entry, stop and target, plus the macro and company-specific catalysts that could re-rate ASE's multiple.
Hillman Solutions is a specialty distributor of fasteners, keys and merchandising solutions showing steady sales growth, free cash flow generation and a valuation that looks reasonable on an EV/EBITDA basis. This trade idea buys a clear recovery narrative — market-share gains in retail merchandising and pricing leverage — with a disciplined stop un…
General Dynamics (GD) just booked a $15.4 billion Navy award for Columbia-class submarines. The contract materially de-risks a large portion of near-term revenue for the Marine Systems business and reinforces free cash flow generation. We outline a tactical long with an entry at $341.00, a stop at $325.00 and a target of $370.00 over a 180 trading-…
Trilogy Metals (TMQ) is a $563M market-cap explorer/developer of the Ambler District in Alaska. The stock is a speculative proxy on executive and federal policy toward domestic critical minerals, plus progress on the company’s 2026 $35M program with South32. This trade idea outlines an entry at $3.25, a stop at $2.60 and a $6.50 target over a 180 t…
Dana Incorporated just lifted its quarterly dividend and doubled its buyback authorization timeline, signaling capital-return confidence while reporting margin improvement. With free cash flow of $298M, EV/EBITDA of 9.7 and room to re-rate toward its 52-week high, Dana looks like a pragmatic tactical long. We lay out an entry, stop and target for a…
State Street is trading at a modest multiple versus earnings and book value despite strong fee revenue trends and record assets under custody. With a current price of $123.44, a trailing EPS near $9.75 and an EV that belies its free cash flow generation, the stock offers a risk/reward profile attractive for a mid-term long. This trade idea lays out…
Willdan Group's combination of improving margins, recurring municipal/utility work and a much-lower valuation base after a 2025 reset creates a compelling mid-term trade. Enter near $76, stop $68, target $110 over a 45-trading-day horizon, with a favorable risk/reward if the company sustains cash flow and backlog conversion.
Cryoport is executing infrastructure and product rollouts that materially lower per-shipment costs and expand addressable capacity for cell and gene therapy logistics. With a market cap below $400M, improving margins, positive ROE/ROA, and a path to near-term breakeven, the stock offers a favorable risk-reward for a position trade. Entry at $7.90, …
Janus International (JBI) looks increasingly attractive at current levels. The stock trades near its 52-week low while the company generates strong free cash flow, carries meaningful cash on the balance sheet, and sits at valuation multiples that imply recovery potential. This trade idea outlines an actionable long with entry, stop, and target alon…
Shake Shack reported 22% revenue growth in Q4 and is guiding to meaningful unit expansion in 2026 while free cash flow is beginning to show positive momentum. At $83.62, the stock trades at an EV/sales of ~2.2 and a lofty P/E near 70 but with improving operating leverage and $1.47B of cash that supports share-price optionality. This trade idea lays…
Badger Meter has reset materially from 2025 highs and now offers a buyable mix of recurring software revenue growth, improving margins and a fortress balance sheet. Valuation has come in to a reasonable multiple for a mid-teens growth story; this note lays out an actionable long-term trade with entry, stop and target and the catalysts and risks tha…
Clorox (CLX) offers a sensible trading opportunity for income-oriented investors able to tolerate a medium level of company-specific risk. At roughly $102 per share, the stock yields near 4.8%, trades at a mid-teens P/E, and is sitting close to its 52-week low after a margin squeeze and a retailer inventory reset shaved expected sales and EPS. The …
Uber is getting dinged by headlines around autonomous partnerships and macro noise, but fundamentals - $9.09B free cash flow, a $143.9B market cap, and healthy margins - suggest the stock is mispriced for a 11-45 trading day rebound. This trade idea lays out an entry, stop, targets, catalysts and the specific risks that could derail the setup.
Corcept Therapeutics popped after the FDA approved Lifyorli for platinum-resistant ovarian, fallopian tube and primary peritoneal cancer. The regulatory green light materially reduces binary regulatory risk and creates a clear commercial catalyst. We upgrade to a buy and lay out an actionable trade: entry $38.12, stop $31.00, primary target $60.00 …
